companydata.dkcompanydata.dk

HEMO Invest ApS: Financial statements 2023

CVR: 38403125

Source: annual report 2023, Danish Business Authority

01/01/2023 – 31/12/2023

HEMO Invest ApS (CVR 38403125) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -61,839 and a net result of DKK 1,477,442 compared with DKK -3,069,301 the year before. Equity in the 2023 report amounted to DKK 28,303,756. The solvency ratio was 99.8%. The company had 1 employee in the financial year.

Gross Profit
DKK -61,839
Profit/Loss
DKK 1,477,442
Equity
DKK 28,303,756
Total Assets
DKK 28,363,442
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023--62K1.5M28.3M1
2022--29K-3.1M27.6M-
2021--55K17.2M30.8M-
2020--43K8.9M13.7M-
2019--18K1.1M5M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

HEMO Invest ApS: The 2022 annual report is outJun 29, 2023

HEMO Invest ApS has published its annual report for 2022. Gross profit came to DKK -29,114, and the net result was DKK -3,069,301.

Auditor steps down at HEMO Invest ApSJun 28, 2023

As of June 28, 2023, EY Godkendt Revisionspartnerselskab has stepped down as auditor of HEMO Invest ApS.

About HEMO Invest ApS

HEMO Invest ApS is a Danish company of the type Anpartsselskab based in Juelsminde, founded in 2016. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Henrik Mortensen. The company is owned by Henrik Mortensen. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -31,106 and a net result of DKK 527,412 compared with DKK 2,192,878 the year before. Equity in the 2025 report amounted to DKK 29,897,046.

Source: annual report 2025, Danish Business Authority